文献库，生知库 | 链接生命科学的每一步

日期影响因子

Suppression of UCP2 alleviates leukemogenesis by enhancing branched-chain amino acids-induced oxidative stress via activating the PI3K/AKT/mTOR signaling pathway.

抑制 UCP2 可通过激活 PI3K/AKT/mTOR 信号通路增强支链氨基酸诱导的氧化应激，从而减轻白血病发生。

期刊:Genes and Diseases

影响因子:9.4

doi:10.1016/j.gendis.2025.101794

Innocent Agida Okohi, Shen Yajie, Gao Yixuan, Sun Ruixin, Aximujiang Kasimujiang, Xu Zizhen, Cheng Jinke, Ma Jiao

发表日期：2026

文献求助收藏

GALNT3 is a novel target driving lymphomagenesis via O-glycosylation of FGFR2.

GALNT3 是一种新型靶点，可通过 FGFR2 的 O-糖基化驱动淋巴瘤的发生。

期刊:Cell Communication and Signaling

影响因子:8.9

doi:10.1186/s12964-025-02599-w

Sun Ruixin, Wang Wenhan, Gao Yixuan, Aximujiang Kasimujiang, Li Yan, Innocent Agida, Xu Zizhen, Ma Jiao

发表日期：2025

文献求助收藏

IRF4 contributes to chemoresistance in IGH::BCL2-positive diffuse large B-cell lymphomas by mediating BCL2-induced SOX9 expression.

IRF4 通过介导 BCL2 诱导的 SOX9 表达，促进 IGH::BCL2 阳性弥漫性大 B 细胞淋巴瘤的化疗耐药性

期刊:Clinical and Translational Medicine

影响因子:6.8

doi:10.1002/ctm2.70336

Zhang Yirong, Xu Zizhen, Sun Ruixin, Gao Yixuan, Agida Innocent, Aximujiang Kasimujiang, Yuan Lin, Ma Jiao

细胞生物学

发表日期：2025

文献求助收藏

Multi-drug resistant Clostridioides difficile isolate ST81 is prominent in hematological patients in a teaching hospital in China

在中国某教学医院的血液病患者中，多重耐药艰难梭菌ST81分离株较为常见。

期刊:Frontiers in Cellular and Infection Microbiology

影响因子:4.8

doi:10.3389/fcimb.2025.1668584

Zhao, Qi; Bian, YaoQian; Wei, XinJun; Xiao, Shuzhen; Xu, Zizhen; Li, Hui; Li, Qingtian; Wei, Beiwen; Huang, Jiewen; Song, Zhen; Zhao, Yanan

发表日期：2025

文献求助收藏

Editorial: Metabolic dysregulation in hematological malignancies: emerging insights and therapeutic implications

社论：血液系统恶性肿瘤的代谢紊乱：新见解和治疗意义

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2025.1701952

Liu, Pengcheng; Ma, Jiao; Xu, Zizhen

发表日期：2025

文献求助收藏

Unveiling hypoxic regulatory networks by bioinformatics: mechanisms of hypoxia-related hub genes driving rituximab resistance and poor prognosis in DLBCL

利用生物信息学揭示缺氧调控网络：缺氧相关枢纽基因驱动利妥昔单抗耐药和弥漫性大B细胞淋巴瘤预后不良的机制

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2025.1592441

Yao, Jiayi; Huang, Juan; Mao, Yuanfei; Xu, Zizhen

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

A predictive model based on immune related genes for diffuse large B cell lymphoma (DLBCL)

基于免疫相关基因的弥漫性大B细胞淋巴瘤（DLBCL）预测模型

期刊:Translational Cancer Research

影响因子:1.7

doi:10.21037/tcr-24-2043

Sun, Ruixin; Liu, Pengcheng; Xu, Zizhen

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma

来那度胺克服了弥漫性大B细胞淋巴瘤临床前模型中对第三代CD19-CAR-T细胞疗法的耐药性

期刊:Cellular Oncology

影响因子:4.8

doi:10.1007/s13402-023-00833-6

Jin, Zhen; Xiang, Rufang; Qing, Kai; Li, Dan; Liu, Zhao; Li, Xiaoyang; Zhu, Hongming; Zhang, Yunxiang; Wang, Lining; Xue, Kai; Liu, Han; Xu, Zizhen; Wang, Yingxiao; Li, Junmin

细胞生物学

免疫/内分泌

发表日期：2023

文献求助收藏

A Novel and Validated 8-Pyroptosis-Related Genes Based Risk Prediction Model for Diffuse Large B Cell Lymphoma

基于8个与细胞焦亡相关的基因的新型且经过验证的弥漫性大B细胞淋巴瘤风险预测模型

期刊:Biomolecules

影响因子:4.8

doi:10.3390/biom12121835

Ma, Junrui; Wang, Wenhan; Ma, Jiao; Xu, Zizhen

细胞生物学

免疫/内分泌

发表日期：2022

文献求助收藏

Role of LATS1/2 in Prognosis of Advanced Gastric Cancer and Its Relationship With the Tumor Immune Microenvironment

LATS1/2在晚期胃癌预后中的作用及其与肿瘤免疫微环境的关系

期刊:Frontiers in Oncology

影响因子:3.5

doi:10.3389/fonc.2020.01406

Yixian Guo, Xu Liu, Danhua Xu, Chen Huang, Zeyu Wang, Xiang Xia, Chunchao Zhu, Jia Xu, Zizhen Zhang, Yanying Shen, Wenyi Zhao, Gang Zhao

发表日期：2020

文献求助收藏